Inici › Leucèmia mieloide aguda › Rhode Island › Providence
Assaigs clínics de Leucèmia mieloide aguda a Providence, RI
10 estudis de Leucèmia mieloide aguda busquen participants en centres de Providence i voltants (en un radi d'uns 30 milles). Obre un estudi per veure qui hi pot participar i com contactar amb l'equip.
Text oficial de l'estudi (anglès)
Comparing Cytarabine + Daunorubicin Therapy Versus Cytarabine + Daunorubicin + Venetoclax Versus Venetoclax + Azacitidine in Younger Patients With Intermediate Risk AML (A MyeloMATCH Treatment Trial)
ReclutantFase 2
- Rhode Island Hospital, Providence
MYELOMATCH: A Screening Study to Assign People With Myeloid Cancer to a Treatment Study or Standard of Care Treatment Within myeloMATCH (MyeloMATCH Screening Trial)
ReclutantFase 2
- Rhode Island Hospital, Providence
Study of Revumenib in Combination With Intensive Chemotherapy in Newly Diagnosed Acute Myeloid Leukemia (AML) With a NPM1 Mutation
ReclutantFase 3
- Clinical Trial Site, Providence
Venetoclax and HMA Treatment of Older and Unfit Adults With FLT3 Mutated Acute Myeloid Leukemia (AML) (A MyeloMATCH Treatment Trial)
ReclutantFase 2
- Rhode Island Hospital, Providence
Comparing New Treatments for People With Newly Diagnosed Acute Myeloid Leukemia That Has an IDH2 Gene Change (A MyeloMATCH Treatment Trial)
ReclutantFase 2
- Rhode Island Hospital, Providence
Testing New Therapies for Patients With Acute Myeloid Leukemia Who Are Newly Diagnosed and Have Not Yet Started Treatment (A MyeloMATCH Treatment Trial)
ReclutantFase 2
- Rhode Island Hospital, Providence
A Study to Compare Standard Chemotherapy to Therapy With CPX-351 and/or Gilteritinib for Patients With Newly Diagnosed AML With or Without FLT3 Mutations
ReclutantFase 3
- Rhode Island Hospital, Providence
The Pediatric Acute Leukemia (PedAL) Screening Trial - A Study to Test Bone Marrow and Blood in Children With Leukemia That Has Come Back After Treatment or Is Difficult to Treat - A Leukemia & Lymphoma Society and Children's Oncology Group Study
ReclutantFase 1/2
- Rhode Island Hospital, Providence
L-Annamycin for Injection in Combination With Cytarabine Injection as Second Line Therapy for Remission Induction in Adult Subjects With Refractory/Relapsed AML
ReclutantFase 2/3
- University of Rhode Island, Providence
Tagraxofusp and Azacitidine With Venetoclax in Newly Diagnosed Secondary AML After Hypomethylating Agents
ReclutantFase 2
- Lifespan Health System Rhode Island Hospital, Providence
Assaigs de Leucèmia mieloide aguda en altres ciutats
- Houston, TX85 estudis
- New York City, NY51 estudis
- Boston, MA44 estudis
- Baldwin Park, CA40 estudis
- Seattle, WA40 estudis
- Columbus, OH35 estudis
- Philadelphia, PA34 estudis
- Durham, NC33 estudis
- Atlanta, GA30 estudis
- Tampa, FL29 estudis
- Chicago, IL26 estudis
- Portland, OR25 estudis
Altres estudis a Providence
- Càncer d'ovari15 estudis
- Càncer d'endometri14 estudis
- Obesitat14 estudis
- Càncer de pulmó de cèl·lules no petites12 estudis
- Càncer (tots els tipus)12 estudis
- Malaltia de Crohn12 estudis
- Colitis ulcerosa11 estudis
- Càncer de mama11 estudis
- Càncer metastàtic9 estudis
- Sobrepès9 estudis
- Malaltia d'Alzheimer8 estudis
- Trastorn per consum d'alcohol (TCA)8 estudis
De ClinicalTrials.gov, dades recuperades el 5 d’oct. 2026. Cada estudi estableix els seus propis criteris d'elegibilitat; l'equip de l'estudi decideix qui hi pot participar.